Journal of the American College of Surgeons
Volume 214, Issue 2 , Pages 164-173 , February 2012

Reduction in Corticosteroids Is Associated with Better Health-Related Quality of Life after Liver Transplantation

Abstract presented at the 2010 Meeting of the International Hepato-Pancreato-Biliary Association, Buenos Aires, Argentina, April 2010.

  • Victor Zaydfudim, MD, MPH

      Affiliations

    • Department of Surgery and Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN
    • Corresponding Author InformationCorrespondence address: Victor Zaydfudim, MD, MPH, Division of Gastroenterologic and General Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905
    • ,
  • Irene D. Feurer, PhD

      Affiliations

    • Department of Surgery and Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN
    • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Matthew P. Landman, MD, MPH

      Affiliations

    • Department of Surgery and Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • Derek E. Moore, MD, MPH

      Affiliations

    • Department of Surgery and Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • J. Kelly Wright, MD, FACS

      Affiliations

    • Department of Surgery and Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • C. Wright Pinson, MBA, MD, FACS

      Affiliations

    • Department of Surgery and Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN

Received 14 July 2011 ,Revised 9 October 2011 ,Accepted 10 October 2011.

References 

  1. Starzl TE , Marchioro TL , Rowlands DT , et al.  Immunosuppression after experimental and clinical homotransplantation of the liver . Ann Surg . 1964;160:411–439
  2. Geissler EK , Schlitt HJ . Immunosuppression for liver transplantation . Gut . 2009;58:452–463
  3. Schacke H , Docke WD , Asadullah K . Mechanisms involved in the side effects of glucocorticoids . Pharmacol Ther . 2002;96:23–43
  4. Henry SD , Metselaar HJ , Van Dijck J , et al.  Impact of steroids on hepatitis C virus replication in vivo and in vitro . Ann N Y Acad Sci . 2007;1110:439–447
  5. Warrington TP , Bostwick JM . Psychiatric adverse effects of corticosteroids . Mayo Clin Proc . 2006;81:1361–1367
  6. Segev DL , Sozio SM , Shin EJ , et al.  Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials . Liver Transpl . 2008;14:512–525
  7. Painter PL , Topp KS , Krasnoff JB , et al.  Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients . Kidney Int . 2003;63:2309–2316
  8. Hilbrands LB , Hoitsma AJ , Koene RA . The effect of immunosuppressive drugs on quality of life after renal transplantation . Transplantation . 1995;59:1263–1270
  9. Feurer ID , Russell RT , Pinson CW . Incorporating quality of life and patient satisfaction measures into a transplant outcomes assessment program: technical and practical considerations . Prog Transplant . 2007;17:121–128
  10. Da Silva JA , Jacobs JW , Kirwan JR , et al.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data . Ann Rheum Dis . 2006;65:285–293
  11. Ware JE , Kosinski M . SF-36® Physical and mental health summary scales: a manual for users of version 1 . 2nd ed.. Lincoln, RI: QualityMetric, Inc; 2001;
  12. Beck A , Steer R . Beck anxiety inventory manual . San Antonio, TX: The Psychological Corporation; 1993;
  13. Russell RT , Feurer ID , Wisawatapnimit P , et al.  The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation . J Gastrointest Surg . 2008;12:138–144
  14. Radloff LS . The CES-D scale: a self-report depression scale for research in the general population . Appl Psychol Meas . 1977;1:385–401
  15. Buttgereit F , Burmester GR , Lipworth BJ . Optimised glucocorticoid therapy: the sharpening of an old spear . Lancet . 2005;365:801–803
  16. Schacke H , Schottelius A , Docke WD , et al.  Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects . Proc Natl Acad Sci U S A . 2004;101:227–232
  17. Stahn C , Buttgereit F . Genomic and nongenomic effects of glucocorticoids . Nat Clin Pract Rheumatol . 2008;4:525–533
  18. McCulloch CE , Searle SR , Neuhaus JM . Generalized, linear and mixed models . 2nd ed.. New York, NY: Wiley; 2008;
  19. Da Silva JA , Jacobs JW , Bijlsma JW . Revisiting the toxicity of low-dose glucocorticoids: risks and fears . Ann N Y Acad Sci . 2006;1069:275–288
  20. van Staa TP , Leufkens HG , Cooper C . The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis . Osteoporos Int . 2002;13:777–787
  21. Gurwitz JH , Bohn RL , Glynn RJ , et al.  Glucocorticoids and the risk for initiation of hypoglycemic therapy . Arch Intern Med . 1994;154:97–101
  22. Dudley T , Chaplin D , Clifford C , Mutimer DJ . Quality of life after liver transplantation for hepatitis C infection . Qual Life Res . 2007;16:1299–1308
  23. Russell RT , Feurer ID , Wisawatapnimit P , et al.  Profile of health-related quality of life outcomes after liver transplantation: univariate effects and multivariate models . HPB (Oxford) . 2008;10:30–37
  24. Pinson CW , Feurer ID , Payne JL , et al.  Health-related quality of life after different types of solid organ transplantation . Ann Surg . 2000;232:597–607
  25. Hansen R , Seifeldin R , Noe L . Medication adherence in chronic disease: issues in posttransplant immunosuppression . Transplant Proc . 2007;39:1287–1300
  26. De Bleser L , Matteson M , Dobbels F , et al.  Interventions to improve medication-adherence after transplantation: a systematic review . Transpl Int . 2009;22:780–797
  27. De Bona M , Ponton P , Ermani M , et al.  The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation . J Hepatol . 2000;33:609–615
  28. Desai R , Jamieson NV , Gimson AE , et al.  Quality of life up to 30 years following liver transplantation . Liver Transpl . 2008;14:1473–1479
  29. Bownik H , Saab S . Health-related quality of life after liver transplantation for adult recipients . Liver Transpl . 2009;15(Suppl):S42–S49

 Disclosure Information: Nothing to disclose.

 This study was supported in part by the National Research Service Award T32 HS 013833 (V.Z.) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services, and an educational award from the Novartis Corporation.

PII: S1072-7515(11)01157-4

doi: 10.1016/j.jamcollsurg.2011.10.006

Journal of the American College of Surgeons
Volume 214, Issue 2 , Pages 164-173 , February 2012

Article Tools

* Image Usage & Resolution